Luan T.-X., Du L., Wang J.-R. et al. · ACS Nano · 2022 · 21565-21575
Open a family to keep every result attached to its sample, method and conditions.
Paraphrased for this database from the authors’ stated interpretations — never quoted verbatim — and kept separate from reported measurements.
PC@PyPor-COF has photodynamic anticancer activity under 660 nm irradiation by triggering singlet oxygen generation.
Caveat: In vitro 4T1-cell result only; authors state future in vivo studies are needed.
21572 · Results and Discussion · Figure 5e; Figures S17-S18 · Linked to 4 structured results
PyPor-COF is an effective Type II photosensitiser for singlet oxygen generation under light irradiation.
Caveat: EPR comparisons are qualitative from plotted signal intensities rather than tabulated quantum yields.
21572 · Results and Discussion · Figure 4 · Linked to 6 structured results
Soybean phosphate/cholesterol composite formation improves PyPor-COF dispersibility for physiological tests.
Caveat: Dispersibility is supported by DLS/photographs; exact formulation optimisation metrics are mostly figure labels rather than tabulated data.
21572 · Results and Discussion · Figures 5b and S14-S16 · Linked to 6 structured results
PyPor-COF is assigned as a 2D crystalline framework with one-dimensional microporous channels.
Caveat: Structure is powder-refined and simulated; no CIF or single-crystal diffraction was supplied.
21569 · Results and Discussion · Figure 2; Figures S2-S4 · Linked to 7 structured results
PyPor-COF was successfully formed as an imidazole-linked porphyrin-pyrene COF.
Caveat: Assignment is based on spectroscopy and model-compound comparison, not single-crystal structure.
21566 · Results and Discussion · Figure 1a,b · Linked to 6 structured results
PyPor-COF has robust thermal and chemical stability.
Caveat: Chemical stability was assessed by retained PXRD peaks after solution exposure; quantitative crystallinity retention was not reported.
21570 · Results and Discussion · Figure 2d,e · Linked to 3 structured results
PyPor-COF behaves as an optically active n-type semiconductor with photoresponsive current generation.
Caveat: Evidence is optical bandgap, Mott-Schottky, and transient photocurrent; no dark electrical conductivity or mobility value is reported.
21570 · Results and Discussion · Figure 3 · Linked to 6 structured results
Names and aliases are kept exactly within the paper’s own identity model.
| Material | Composition | Structure context | Source |
|---|---|---|---|
| model compound | Not specifiednone · PyTO, benzaldehyde, and ammonium acetate reaction product | 0D · Model Systemsmall-molecule/model imidazole product for NMR comparison | S5 · Experimental section |
| 5,10,15,20-tetrakis(4-benzaldehyde)porphyrin (p-Por-CHO) | Not specifiednone · metal-free porphyrin aldehyde precursor | 0D · Model Systemporphyrin aldehyde precursor/control | 21566 · Results and Discussion |
| PC@PyPor-COF | Not specifiednone · PyPor-COF mixed with soybean phosphate and cholesterol | unknown · Compositeliposome/dispersibility composite of PyPor-COF for physiological tests | 21572 · Results and Discussion · Figure 5b, Figures S14-S16 |
| PyPor-COF | Not specifiednone; metal-free covalent organic framework · PyTO, 5,10,15,20-tetrakis(4-benzaldehyde)porphyrin (p-Por-CHO), and ammonium acetate-derived imidazole linkages | 2D · Pristine2D imidazole-linked porphyrin-pyrene COF; AA stacking model; P4/m space group; one-dimensional porous channels | 21566 · Results and Discussion · Scheme 1d |
| pyrene-4,5,9,10-tetraone (PyTO) | Not specifiednone · pyrene tetraone precursor | 0D · Model Systemorganic diketone precursor/control | 21566 · Results and Discussion |
Sample form, processing state and composition status define the context for measurements.
| Sample | Form and role | Processing and geometry | Source |
|---|---|---|---|
| model compoundresearch_0766__mat__mat_model_compound | Model · Model System · Model | dark black powder, Soxhlet extracted and dried under vacuum at 120 deg C overnight | S5 · Synthesis of Model Compound |
| p-Por-CHO precursor/controlresearch_0766__mat__mat_p_por_cho | Powder · Pristine Control · Model | commercial or prepared precursor; synthesis not reported in this paper | 21566 · Results and Discussion |
| PC@PyPor-COF compositeresearch_0766__mat__mat_pc_pypor_cof | Powder · Composite Sample · Composite | PyPor-COF mixed with cholesterol and soybean phosphate, stirred in water, centrifuged, washed, dried | S5-S6 · Praparation of PC@PyPor-COF |
| activated PyPor-COFresearch_0766__mat__mat_pypor_cof | Powder · Target Sample · Pristine Framework | activated/degassed before porosity and stability measurements | S2 · General information |
| as-synthesized PyPor-COF powderresearch_0766__mat__mat_pypor_cof | Powder · Target Sample · Pristine Framework | washed, Soxhlet extracted, dried under vacuum at 120 deg C overnight | 21573 · Experimental Section |
| sonicated PyPor-COF nanoparticlesresearch_0766__mat__mat_pypor_cof | Nanosheet · Target Sample · Pristine Framework | ultrasonic exfoliation to reduce aggregate size for cell experiments | 21571 · Results and Discussion · Figure 5a |
| PyTO precursor/controlresearch_0766__mat__mat_pyto | Powder · Pristine Control · Model | golden powder after column chromatography | S4 · Synthesis of pyrene-4,5,9,10-tetraone (PyTO) · Scheme S1 |